Matthew P. Kowalsky's most recent trade in Enanta Pharmaceuticals Inc was a trade of 90,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Nov. 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enanta Pharma Inc | Matthew P. Kowalsky | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2025 | 90,000 | 90,000 | - | - | Stock Option (right to buy) |